HEALTH

17/08/2012

Nice: Jean Jacques Romatet, new President of CNR Healthcare at Home and Autonomy

Jean Jacques Romatet succeeds Professor Alain Franco in the Presidency at CNR Healthcare at Home and Autonomy, based in Nice.


 

This article was published on July, 12th.

 

Nice, Côte d’Azur benefits from an important research and care ecosystem built around the CHU in Nice. At the heart of this ecosystem the Centre National de Référence, Healthcare at Home and Autonomy, created in 2009 at the initiative of the Minister of Economy, Industry and Employment,  continues the mission to encourage the development and correct use of digital solutions for the management of health and support for autonomy of the individual at home. Its aim is to raise awareness of the economic benefits on the interest of ICT in the management of health and independence in the home, to drive strategic initiatives and collective actions to identify new economic models, or even map talents and select the best partners.

 

During the Annual General Meeting of 2nd July, Jean Jacques Romatet, previously Vice President at the centre in charge of the policy committee, was elected President of the Centre National de Référence Healthcare at Home and Autonomy and succeeds Professor Alain Franco. Managing Director since 2007 of the CHU in Toulouse, Jean Jacques Romatet is the Midi-Pyrénées regional representative of the Fédération Hospitalière de France (French Hospital Federation). He was Advisor to Health Ministers for the implementation and application of reforms of hospital governance and is President of Centre e-santé (e-health centre) in Toulouse and founder of the innovation and evaluation e-health platform “PlatinneS”.

 

In order to carry out his mission, Jean Jacques Romatet is surrounded by an office made up of members representing all stakeholders of the innovation:

-        Giovanni Ungaro (LEGRAND) Vice-President responsible of the Policy Committee

-        Professor Thierry Dantoine (ELOPSYS competitiveness pole) Vice-President responsible for the Science Committee

-        Isabelle Hebert (MALAKOFF MEDERIC) Vice-President responsible for Ethical Space

-        Richard Seccone (Link Care Services) Secretary

-        Philippe Caton (COVEA) Treasurer

 

With this new presidency, the Centre addresses the second phase of its mission, which will focus on the creation of an economic structure. Its growing status and the 80 structures that it federates allows it to fully play its role of deployment accelerator of e-health in France.

 

Extending roadmap 2010-2012, roadmap 2012-2015 will be completed by new services accelerating the structure of the sector and the development of products or numerical services that respond to the needs expressed by the market:

-         The labelling of products and services, affected independently and in a neutral manner, thanks to a commission that will be in operation from the start of 2013,

-         Market analysis of healthcare in the home and autonomy susceptible to include digital solutions,

-         Project evaluation to help promoters and consortiums in the development of responses to calls for projects or clients’ requests,

-         Information from policy-makers by making educational documents on key themes available.


En savoir plus : www.cnr-sante.fr/

Contact

They chose the Côte d'Azur

"Sophia-Antipolis is a very attractive region for any semiconductor company, for several reasons. The first one is that in the technology park of Sophia-Antipolis there is a solid tradition of analog and digital design, which is due to the presence of other big companies working in the same or similar markets, like Texas Instruments, Intel, STM and others. The second reason is linked to presence in the technology park of the Polytech'Nice-Sophia and other important schools.

That will guarantee our future growth since the region will always offer both experienced design engineers and you talents to hire."

Interview with Paolo Cusinato, Design Director of MAXIM Sophia-Antipolis design center

Key Facts & Figures

 

Annual turnover: 2.3 billion euros

Companies: 245

Jobs: 9,130

Fields of activity: Biotechnologies, Biomaterials, Chemistry, Cosmetology, Biomedical Engineering, Health Image and Software, Medical Instrumentation, Pharmaceutical & Veterinary Industrie, Pharmacology, Agronomy.

 

 

 

 

Leaders:  Arkopharma, Asepta, Bayer Cropsciences, CLL Pharma, Dow Agrosciences, Galderma, IRIS Pharma, Integra Neurosciences Implants, Laboratoires Boiron, Laboratoires Genévrier, Lundbeck/Elaiapharm, MXM, NicOx, Txcell, Virbac

Success Stories: Iris Pharma, Median Technologies, Neomah, Neurelec, Nicox, Quantificare, Senseor, Virbac, Theralpha, Txcell,  VenomeTech,...

Competitive Clusters : EUROBIOMED Biocluster